Hyperfine (HYPR)
NASDAQ:HYPR
Earnings Data
Report Date
May 07, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.09Last Year’s EPS
-0.12Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed meaningful commercial and operational progress: a breakout Q4 with strong unit sales and 128% Q4 revenue growth, sustained gross margin expansion above 50%, reduced cash burn, robust clinical and health-economic validation, and strengthened financing that extends runway into 2028. Counterbalancing these positives are a modest full-year revenue increase (5%), continued net losses, dependence on larger multi-hospital/IDN deals that can create quarter-to-quarter lumpiness, some accounting-driven service revenue variability, and phased international rollouts that delay certain revenue streams. Overall the company appears to be transitioning successfully from development to commercial scale but still faces execution and timing risks tied to larger deals and international expansion.Company Guidance
Strong Q4 Revenue and Unit Growth
Q4 revenue of $5.3M, up 128% vs. $2.3M in Q4 2024; 16 units sold in Q4 2025 vs. 9 units in Q4 2024; second-half 2025 revenue $8.7M vs. $4.8M in first half.
Gross Margin Expansion and Profitability Trends
Q4 gross profit $2.7M (gross margin 50.9%), second straight quarter >50%; Q4 gross margin expanded +1,530 basis points YoY. Full year 2025 gross margin 49.8%, +410 bps YoY.
Improved Operating Efficiency and Lower Cash Burn
R&D down 25% in Q4 and 22% for FY; Q4 net cash burn excluding financing $5.7M, down 30% YoY; FY net cash burn excluding financing $29.9M, down 22% YoY.
Stronger Net Loss Position
Q4 net loss narrowed to $5.9M (–$0.06 per share) vs. $10.4M (–$0.14) prior-year quarter; full year net loss improved to $35.6M (–$0.43) vs. $40.7M (–$0.56) in 2024 (includes noncash warrant gains).
Capital Strength and Extended Runway
Raised >$20M equity (Oct 2025) and secured $15M initial tranche of up to $40M debt facility; cash balance $35.1M at year-end (inclusive of Oct equity proceeds) and company expects runway into 2028.
Ambitious 2026 Guidance
Full-year 2026 revenue guidance $20M–$22M (midpoint ~55% YoY growth); gross margin guidance 50%–55%; total cash burn guidance $26M–$28M (≈10% YoY decline at midpoint).
Clinical and Regulatory Validation
FDA clearance in Dec 2025 for Optive AI upgrade (11th software generation) enhancing diffusion-weighted imaging; NEURO-PMR showed 92% concordance (blinded) and 98% concordance (unblinded) vs. high-field MRI; Yale PRIME study completed enrollment ahead of schedule.
Health Economic Evidence and Commercial Momentum
Published health economic impact data (Jefferson Abington, 143 scans) showing cost savings and modeled 1–1.5 year ROI for hospitals; market activation with larger IDN and multi-placement discussions; over a dozen next-generation systems sold since June.
International and Market Expansion
Optive AI released in 10 European languages; regulatory approval obtained in India (launch planned with local partner); plans to pursue CE/UK approvals and phased international rollout in H2 2026.
HYPR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HYPR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 18, 2026 | $1.27 | $1.21 | -4.72% |
Nov 13, 2025 | $1.05 | $1.15 | +9.52% |
Aug 13, 2025 | $1.27 | $1.45 | +14.17% |
May 13, 2025 | $0.70 | $0.61 | -12.45% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Hyperfine (HYPR) report earnings?
Hyperfine (HYPR) is schdueled to report earning on May 07, 2026, After Close (Confirmed).
What is Hyperfine (HYPR) earnings time?
Hyperfine (HYPR) earnings time is at May 07, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is HYPR EPS forecast?
HYPR EPS forecast for the fiscal quarter 2026 (Q1) is -0.09.